Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
Clinical trial NCT01313676 · COMPLETED
Trial details
- NCT number
- NCT01313676
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-25
- Primary completion
- 2015-07-15
- Enrollment
- 16568
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.